Genetics of Hypertriglyceridemia and Emerging Therapies

From the NLA 2013 Fall Clinical Lipid Update

Daniel Gaudet discusses Genetics of Hypertriglyceridemia and Emerging Therapies.

View Presentation

No votes yet
Activity Classification

This activity is instructional only and may not be taken for credit.

Content Domain
This activity falls under the following content domain(s):

Learning Objectives
This activity teaches to the following learning objective(s):

  1. Assess the status of new and emerging treatment options for cholesterol and triglyceride management

Copyright © 2018 National Lipid Association. All Rights Reserved.

Privacy Policy Terms of Service